Lonza Amaxa 4D-Nucleofector system
The Amaxa Nucleofector technology is claimed to be the first efficient non-viral transfection method for primary cells and hard-to-transfect cell lines.
With a new platform, the 4D-Nucleofector system enables nucleofection of cells in several formats, combined with good performance and convenience.
Its features include: transfection of variable cell numbers with same conditions; choice of throughputs from 1 to 16 wells in just 10 s; nucleofection of adherent cells for functional assays at various cellular stages.
The modular system will accommodate upcoming transfection challenges and a current transfection protocol database is available with 690 cells listed, which is continuously updated.
Phone: 1300 657508
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...
Learn More
I am interested in Lonza Amaxa 4D-Nucleofector system.
Complete the form and a supplier representative will be in touch.
